Skip to main navigation Skip to search Skip to main content

A phase 3 randomized double blind placebo controlled study to evaluate the efficacy and safety of anti spike SARS-CoV-2 monoclonal antibodies as pre-exposure prophylaxis to prevent COVID-19 in immunocompromised participants

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date11/17/21 → 11/16/22

Funding

  • Regeneron Pharmaceuticals Incorporated: $23,829.00